Your browser does not support JavaScript!

9th Floor, Empire Heights Tower A, Shuraa Gold Business Centre , Business Bay 79998 Dubai AE
JollyRX
9th Floor, Empire Heights Tower A, Shuraa Gold Business Centre , Business Bay Dubai, AE
+971585996347 //cdn1.storehippo.com/s/6052eead9e1cf8aa024c48c8/606ecab786617735b12707ae/webp/jollyrx-480x480.png" contact@jollyrx.com
6291538a340a90ca008f154d Adcetris ( Brentuximab Vedotin ) 50 Mg/vial //cdn1.storehippo.com/s/6052eead9e1cf8aa024c48c8/6291551c340a90ca008f2eb0/webp/brentuximab.jpg

Adcetris | Brentuximab Vedotin | Details, Costing & Pricing

The active ingredient in Adcetris is brentuximab vedotin. Adcetris contains a monoclonal antibody as well as a chemotherapeutic medication. Adcetris reduces the number of lymphoma cancer cells in the body. It is a type of targeted therapy for lymphoma. This signifies that the medicine specifically targets and eliminates cancer cells. When compared to typical chemotherapy, the goal of targeted therapy is to have a lower impact on healthy cells.

Adcetris is only available in one dosage: 50 milligram (mg). It comes in a single-dose container as a powder. The powder is combined into a liquid solution, which is then administered as an intravenous (IV) infusion by your healthcare professional. (An IV infusion is when the medicine is slowly infused into your vein). Adcetris infusions will most likely be given every 2 or 3 weeks.

USES OF ADCETRIS INJECTION

  • In treatment of lymphoma

BENEFITS OF ADCETRIS INJECTION

Classical Hodgkin lymphoma (cHL)

Adcetris treats cHL that either :

  • Is stage 3 or stage 4 and has not been treated yet.
  • Has a high risk of relapse (coming back) or progression (getting worse) after a stem cell transplant.
  • Has relapsed after having a stem cell transplant. Or, has relapsed after at least two sessions of chemotherapy with various medicines if a stem cell transplant is not possible.

Certain types of T-cell lymphoma

Adcetris is used to treat the following types of T-cell lymphoma, which are also non-Hodgkin lymphoma. :

  • Certain types of peripheral T-cell lymphoma, including systemic anaplastic large cell lymphoma (sALCL), that haven’t been treated yet.
  • sALCL that’s relapsed after at least one course of chemotherapy with multiple drugs.
  • Primary cutaneous anaplastic large cell lymphoma and a type of mycosis fungoides, either of which have relapsed after systemic treatment.

SIDE EFFECTS OF ADCETRIS INJECTION

Most of the adverse effects should disappear within a few days or weeks. However, if they worsen or do not go away, consult your doctor or pharmacist.

common side effects

  • infusion-related reactions
  • fatigue (lack of energy)
  • nausea and vomiting
  • diarrhea
  • constipation
  • abdominal (belly) pain
  • upper respiratory tract infections, such as the common cold
  • fever
  • hair loss
  • weight loss
  • stomatitis (soreness or inflammation inside your mouth)
  • mucositis (inflammation or ulcers on the lining of your digestive tract)

serious side effects

  • Lung problems (lung inflammation or respiratory distress syndrome)
  • Liver damage
  • Serious skin reactions
  • Pancreatitis (inflammation of your pancreas)
  • Digestive problems (ulcers, bleeding, inflammation, tears, or blockages in your stomach or intestines)
  • Anaphylaxis (allergic reaction)
  • Peripheral neuropathy (nerve damage in your hands and feet)
  • low levels of red blood cells or white blood cells
  • High blood sugar level
  • Progressive multifocal leukoencephalopathy (a severe disorder induced by a viral infection in the brain)

HOW TO USE ADCETRIS INJECTION

This medication will be administered to you by your doctor or nurse. Kindly do not self administer.

STORAGE

Adcetris should be kept in a refrigerator between 2°C and 8°C. To protect the medicine from light keep the vial in the carton.

Is Adcetris a chemotherapy drug?

Adcetris is a cancer treatment that is not a standard chemotherapy. Adcetris combines an antibody with a cancer medication, with the antibody directing the drug to the CD30 target on lymphoma cancer cells.

How and where is Adcetris administered?

Adcetris (brentuximab vedotin) is administered intravenously (IV) into a vein in a doctor's office or outpatient clinic. Depending on your illness, the infusion is normally administered every 2 or 3 weeks. Adcetris is a cancer therapy used to treat several types of lymphoma (blood cancer).

For more information, visit - 

SKU-1LPRGV9CRF6U
in stock INR
1 1

Adcetris ( Brentuximab Vedotin ) 50 Mg/vial


Product Enquiry

Sold By: jollyrx
VARIANT SELLER PRICE QUANTITY

Description of product

Adcetris | Brentuximab Vedotin | Details, Costing & Pricing

The active ingredient in Adcetris is brentuximab vedotin. Adcetris contains a monoclonal antibody as well as a chemotherapeutic medication. Adcetris reduces the number of lymphoma cancer cells in the body. It is a type of targeted therapy for lymphoma. This signifies that the medicine specifically targets and eliminates cancer cells. When compared to typical chemotherapy, the goal of targeted therapy is to have a lower impact on healthy cells.

Adcetris is only available in one dosage: 50 milligram (mg). It comes in a single-dose container as a powder. The powder is combined into a liquid solution, which is then administered as an intravenous (IV) infusion by your healthcare professional. (An IV infusion is when the medicine is slowly infused into your vein). Adcetris infusions will most likely be given every 2 or 3 weeks.

USES OF ADCETRIS INJECTION

  • In treatment of lymphoma

BENEFITS OF ADCETRIS INJECTION

Classical Hodgkin lymphoma (cHL)

Adcetris treats cHL that either :

  • Is stage 3 or stage 4 and has not been treated yet.
  • Has a high risk of relapse (coming back) or progression (getting worse) after a stem cell transplant.
  • Has relapsed after having a stem cell transplant. Or, has relapsed after at least two sessions of chemotherapy with various medicines if a stem cell transplant is not possible.

Certain types of T-cell lymphoma

Adcetris is used to treat the following types of T-cell lymphoma, which are also non-Hodgkin lymphoma. :

  • Certain types of peripheral T-cell lymphoma, including systemic anaplastic large cell lymphoma (sALCL), that haven’t been treated yet.
  • sALCL that’s relapsed after at least one course of chemotherapy with multiple drugs.
  • Primary cutaneous anaplastic large cell lymphoma and a type of mycosis fungoides, either of which have relapsed after systemic treatment.

SIDE EFFECTS OF ADCETRIS INJECTION

Most of the adverse effects should disappear within a few days or weeks. However, if they worsen or do not go away, consult your doctor or pharmacist.

common side effects

  • infusion-related reactions
  • fatigue (lack of energy)
  • nausea and vomiting
  • diarrhea
  • constipation
  • abdominal (belly) pain
  • upper respiratory tract infections, such as the common cold
  • fever
  • hair loss
  • weight loss
  • stomatitis (soreness or inflammation inside your mouth)
  • mucositis (inflammation or ulcers on the lining of your digestive tract)

serious side effects

  • Lung problems (lung inflammation or respiratory distress syndrome)
  • Liver damage
  • Serious skin reactions
  • Pancreatitis (inflammation of your pancreas)
  • Digestive problems (ulcers, bleeding, inflammation, tears, or blockages in your stomach or intestines)
  • Anaphylaxis (allergic reaction)
  • Peripheral neuropathy (nerve damage in your hands and feet)
  • low levels of red blood cells or white blood cells
  • High blood sugar level
  • Progressive multifocal leukoencephalopathy (a severe disorder induced by a viral infection in the brain)

HOW TO USE ADCETRIS INJECTION

This medication will be administered to you by your doctor or nurse. Kindly do not self administer.

STORAGE

Adcetris should be kept in a refrigerator between 2°C and 8°C. To protect the medicine from light keep the vial in the carton.

Is Adcetris a chemotherapy drug?

Adcetris is a cancer treatment that is not a standard chemotherapy. Adcetris combines an antibody with a cancer medication, with the antibody directing the drug to the CD30 target on lymphoma cancer cells.

How and where is Adcetris administered?

Adcetris (brentuximab vedotin) is administered intravenously (IV) into a vein in a doctor's office or outpatient clinic. Depending on your illness, the infusion is normally administered every 2 or 3 weeks. Adcetris is a cancer therapy used to treat several types of lymphoma (blood cancer).

For more information, visit - 

User reviews

  0/5